Contact
searchSearch
HMP Global
ISET 2026

What Is the Role of Specialty Balloons in the Tibial Vessels?

Fabrizio Fanelli, MD
03/30/2026

In this video, interventional radiologist Fabrizio Fanelli, MD, from Careggi University Hospital in Florence, Italy, explores the evolving role of specialty balloons in the treatment of tibial vessel disease. Discussing his presentation at ISET 2026, Dr. Fanelli highlights how these advanced devices are being used to address complex below-the-knee lesions, improve procedural outcomes, and expand options for patients with chronic limb-threatening ischemia.

© 2026 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Critical Limb Ischemia or HMP Global, their employees, and affiliates.

Related Content

Literature Review
Outcomes in Patients With and Without Chronic Limb-Threatening Ischemia: A Systematic Literature Review on Atherectomy for Peripheral Interventions
03/31/2026
Jeffrey G. Carr, MD, FACC, FSCAI; Ralf Langhoff, MD; Brian DeRubertis, MD, FACS; Kristin L. Hood, PhD; Prakash Krishnan, MD, FACC; Vikram Puttaswamy, MD; Thomas Zeller, MD, PhD; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
In this literature review, the authors aim to comprehensively summarize the evidence quality and clinical outcomes following peripheral atherectomy in patients with and without CLTI.
In this literature review, the authors aim to comprehensively summarize the evidence quality and clinical outcomes following peripheral atherectomy in patients with and without CLTI.
In this literature review, the...
03/31/2026
Journal of Critical Limb Ischemia
Editorial/Commentary
Atherectomy for Peripheral Interventions: Evidence and Clinical Considerations
03/31/2026
Dipankar Mukherjee, MD, FACS; Richard Neville, MD
The authors comment on the article by Carr et al, "Outcomes in Patients With and Without Chronic Limb-Threatening Ischemia: A Systematic Literature Review on Atherectomy for Peripheral Interventions".
The authors comment on the article by Carr et al, "Outcomes in Patients With and Without Chronic Limb-Threatening Ischemia: A Systematic Literature Review on Atherectomy for Peripheral Interventions".
The authors comment on the...
03/31/2026
Journal of Critical Limb Ischemia
Case Series
Deep Vein Arterialization for Acute Limb Ischemia: Initial Experience in Three Patients
03/13/2026
Anxhela Hasanlli, MD; John H. Rundback, MD, FAHA, FSVM, FSIR; Kevin Herman, MD; Edel Mendoza, MD
The authors present a retrospective case series of 3 patients with ALI who underwent DVA due to persistent, unresolvable limb-threatening tibiopedal occlusive disease after failed endovascular or surgical procedures.
The authors present a retrospective case series of 3 patients with ALI who underwent DVA due to persistent, unresolvable limb-threatening tibiopedal occlusive disease after failed endovascular or surgical procedures.
The authors present a...
03/13/2026
Journal of Critical Limb Ischemia
Narrative Review
System Matters: How Structure and Access Shape CLTI Outcomes
02/23/2026
Eric Ducasse, MD, PhD; Xavier Bérard, MD, PhD; Caroline Caradu, MD, PhD
This review examines CLTI as a systems disease, focusing on failure points in recognition, referral, and access; why delays translate into limb loss and death; organizational models that mitigate delay; and more.
This review examines CLTI as a systems disease, focusing on failure points in recognition, referral, and access; why delays translate into limb loss and death; organizational models that mitigate delay; and more.
This review examines CLTI as a...
02/23/2026
Journal of Critical Limb Ischemia

News

Clinical Trials
Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease/Chronic Limb Threatening Ischemia
03/12/2026
HELSINKI, March 12, 2026 (GLOBE NEWSWIRE) -- Aplagon, a clinical stage biotech pioneering a first-in-class treatment for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and anticoagulant...
HELSINKI, March 12, 2026 (GLOBE NEWSWIRE) -- Aplagon, a clinical stage biotech pioneering a first-in-class treatment for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and anticoagulant...
HELSINKI, March 12, 2026 (GLOBE...
03/12/2026
Journal of Critical Limb Ischemia
Radiation Safety
Rampart Launches SECURE Clinical Program to Advance Clinical Evidence for Next Generation Radiation Protection
01/08/2026
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
First-of-its-Kind,...
01/08/2026
Journal of Critical Limb Ischemia
Dr van den Berg
AMP 2025
Jos van den Berg, MD, PhD, Highlights the Growing Economic Burden of CLTI in Europe
08/14/2025
Jos C. van den Berg, MD, PhD
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional...
08/14/2025
Journal of Critical Limb Ischemia
DR NEVILLE
AMP 2025
Evolving Metrics: Dr Richard Neville Explains How Quality Assessment in CLTI Care Is Being Re-Engineered
08/14/2025
Richard Neville, MD
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines...
08/14/2025
Journal of Critical Limb Ischemia

Stay in the Know

Journal of Critical Limb Ischemia Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use